Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

DiaPlexQ™ RV16 Detection Kit (with SARS-CoV-2)

Manufactured by SolGent Co. Ltd., South Korea - http://www.solgent.com 

Device identification number
5786
CE Marking
Yes
HSC common list (RAT)
×No
Format
Manual
Physical Support
Other (tube)
Target type
Nucleic acid
Targets
nucleocapsid protein/gene, ORF1a polyprotein/gene, Other (RdRp gene)
Specimen
Nasopharyngeal swab, Other (Nasopharyngeal and Oropharyngeal swab), Sputum
Cross-reactivity (pathogens tested)
Beta Coronavirus HKU1 (HCoV-HKU1), Bordetella Pertussis, Hemophilus Influenzae, MERS-CoV, Mycobacterium Tuberculosis, Mycoplasma Pneumoniae, Other (), SARS-CoV
Pathogens detected
Adenovirus, Alpha Coronavirus 229E (HCoV-229E), Alpha Coronavirus Nl63 (HCoV-Nl63), Beta Coronavirus OC43 (HCoV-OC43), Human Metapneumovirus (HMPV), Influenza A, Influenza B, Other (Rhinovirus C, Enterovirus, Bocavirus), Parainfluenza Virus Type 1, Parainfluenza Virus Type 2, Parainfluenza Virus Type 3, Parainfluenza Virus Type 4, Respiratory Syncytial V (RSV) Type A, Respiratory Syncytial V (RSV) Type B, Rhinovirus A, Rhinovirus B, SARS-CoV-2
Commercial Status
Commercialised
Last Update
2022-11-29 09:15:50 CET
Assay Type
Nucleic acid-PCR
Rapid Diagnostic
No
Self Test
No
Reader Required
N.A.
Subcategory
N.A.
Method
RT-PCR
Measurement
Qualitative
Time
110 minutes
Subclass
N.A.
Detection Principle
Fluorescence

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements